RxDoctor Payments Data

Joel Griffith

Psychiatric/Mental Health · Frederick, MDNPI 1508338203

Payments from drug & device makers

$902in general payments, 2019–2025

Across 40 payments — averaging $22.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$250
  • Teva Pharmaceuticals USA, Inc.$243
  • Otsuka America Pharmaceutical, Inc.$185
  • Johnson & Johnson$69
  • E.r. Squibb & Sons, L.L.C.$48
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$46
  • plus $60 from 2 others

What the payments were for

  • Food & beverage$79788%
  • Education$10612%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$902 in reported general payments places this provider in the 70th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$59,947
Medicare patients
86
Services billed
574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate44$136,826
Abilify MaintenaAripiprazole28$75,124
PerserisRisperidone15$44,912
Risperidone ErRisperidone Microspheres19$35,996
Paliperidone ErPaliperidone68$31,237
Risperdal ConstaRisperidone Microspheres19$27,475
VyvanseLisdexamfetamine Dimesylate38$21,519
RexultiBrexpiprazole12$18,254
Clozapine127$13,636
Atomoxetine Hcl75$12,473
Aripiprazole75$12,292
Olanzapine382$9,921
Asenapine Maleate20$8,919
Divalproex Sodium321$8,361
Ziprasidone Hcl76$7,830

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$69$164,30163 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$185$93,37740 claims
Indivior Inc.Perseris$29$44,91215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,461 psychiatric/mental health providers in Maryland.

Other psychiatric/mental health in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →